Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingkun Xu

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Oxidative Medicine and Cellular Longevity|December 24, 2021
Erratum to "Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-<i>κ</i>B Axis"Chenglin Han, Zilong Wang, Shuxiao Chen, et al.
Biomed Research International|September 10, 2020
TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In VitroYingkun Xu, Guangzhen Wu, Jiayao Zhang, et al.
PPAR Research|October 8, 2020
A New Prognostic Risk Model Based on PPAR Pathway-Related Genes in Kidney Renal Clear Cell CarcinomaYingkun Xu, Xiunan Li, Yuqing Han, et al.
Journal of Cancer|October 30, 2020
Genetic alteration and clinical significance of SUMOylation regulators in multiple cancer typesGuangzhen Wu, Yingkun Xu, Ningke Ruan, et al.
International Journal of Genomics|December 31, 2020
Identification of CPT1A as a Prognostic Biomarker and Potential Therapeutic Target for Kidney Renal Clear Cell Carcinoma and Establishment of a Risk Signature of CPT1A-Related GenesYingkun Xu, Guangzhen Wu, Xue Ma, et al.
Frontiers in Medicine|May 6, 2026
Machine learning-driven multi-omics integration of urinary organic acids and ions enables precision risk stratification for calcium oxalate nephrolithiasisPeizhi Zhang, Yang Liu, Boxing Su, et al.
Oxidative Medicine and Cellular Longevity|February 1, 2021
Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-<i>κ</i>B AxisChenglin Han, Zilong Wang, Shuxiao Chen, et al.
Bioengineered|October 12, 2021
A new prognostic risk model based on autophagy-related genes in kidney renal clear cell carcinomaGuangzhen Wu, Yingkun Xu, Huayu Zhang, et al.
Biomed Research International|February 13, 2020
Screening and Identification of Key Biomarkers for Bladder Cancer: A Study Based on TCGA and GEO DataYingkun Xu, Guangzhen Wu, Jianyi Li, et al.
Journal of Oncology|July 1, 2022
ARL4C Regulates the Progression of Clear Cell Renal Cell Carcinoma by Affecting the Wnt/<i>β</i>-Catenin Signaling PathwayPeizhi Zhang, Yingkun Xu, Shaoan Chen, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Oxidative Medicine and Cellular Longevity|December 24, 2021
Erratum to "Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-<i>κ</i>B Axis"Chenglin Han, Zilong Wang, Shuxiao Chen, et al.
Biomed Research International|September 10, 2020
TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In VitroYingkun Xu, Guangzhen Wu, Jiayao Zhang, et al.
PPAR Research|October 8, 2020
A New Prognostic Risk Model Based on PPAR Pathway-Related Genes in Kidney Renal Clear Cell CarcinomaYingkun Xu, Xiunan Li, Yuqing Han, et al.
Journal of Cancer|October 30, 2020
Genetic alteration and clinical significance of SUMOylation regulators in multiple cancer typesGuangzhen Wu, Yingkun Xu, Ningke Ruan, et al.
International Journal of Genomics|December 31, 2020
Identification of CPT1A as a Prognostic Biomarker and Potential Therapeutic Target for Kidney Renal Clear Cell Carcinoma and Establishment of a Risk Signature of CPT1A-Related GenesYingkun Xu, Guangzhen Wu, Xue Ma, et al.
Frontiers in Medicine|May 6, 2026
Machine learning-driven multi-omics integration of urinary organic acids and ions enables precision risk stratification for calcium oxalate nephrolithiasisPeizhi Zhang, Yang Liu, Boxing Su, et al.
Oxidative Medicine and Cellular Longevity|February 1, 2021
Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-<i>κ</i>B AxisChenglin Han, Zilong Wang, Shuxiao Chen, et al.
Bioengineered|October 12, 2021
A new prognostic risk model based on autophagy-related genes in kidney renal clear cell carcinomaGuangzhen Wu, Yingkun Xu, Huayu Zhang, et al.
Biomed Research International|February 13, 2020
Screening and Identification of Key Biomarkers for Bladder Cancer: A Study Based on TCGA and GEO DataYingkun Xu, Guangzhen Wu, Jianyi Li, et al.
Journal of Oncology|July 1, 2022
ARL4C Regulates the Progression of Clear Cell Renal Cell Carcinoma by Affecting the Wnt/<i>β</i>-Catenin Signaling PathwayPeizhi Zhang, Yingkun Xu, Shaoan Chen, et al.
Pageof 7